Evonik Evonik

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find the latest news about VelosBio aggregated by PharmaCompass.com.

    Client Virtual Booth

    VELOSBIO

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    VelosBio
    United_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    11045 Roselle Street, Suite 130 San Diego CA 92121
    Telephone
    Telephone
    +1 (858) 461-6666
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://velosbio.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/velosbioinc
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    Merck acquires VelosBio: exploring the promise of ROR1 in cancer
    Merck acquires VelosBio: exploring the promise of ROR1 in cancer

    https://www.pharmaceutical-technology.com/features/merck-velosbio-ror1-cancer/

    Allie Nawrat PHARMACEUTICAL TECHNOLOGY
    19 Nov 2020
    Share Share
    Merck to bolster cancer drug portfolio with VelosBio $2.75 billion deal
    Merck to bolster cancer drug portfolio with VelosBio $2.75 billion deal

    https://in.reuters.com/article/us-merck-co-deals/merck-to-bolster-cancer-drug-portfolio-with-velosbio-2-75-billion-deal-idINKBN27L1G8

    Ankur Banerjee REUTERS
    06 Nov 2020
    Share Share
    VelosBio doses first patient in Phase II solid tumour drug trial
    VelosBio doses first patient in Phase II solid tumour drug trial

    https://www.biospace.com/article/releases/velosbio-announces-first-patient-dosed-in-phase-2-trial-of-vls-101-in-solid-tumors-/

    BIOSPACE
    19 Oct 2020
    Share Share
    VelosBio gets FDA Designations for VLS-101 in Patients with Mantle Cell Lymphoma
    VelosBio gets FDA Designations for VLS-101 in Patients with Mantle Cell Lymphoma

    https://www.businesswire.com/news/home/20200831005097/en/VelosBio-Announces-FDA-Fast-Track-Orphan-Drug

    BUSINESSWIRE
    31 Aug 2020
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    euroapi-2024-05-06

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search